60
Participants
Start Date
October 30, 2020
Primary Completion Date
April 25, 2023
Study Completion Date
March 15, 2024
IBE-814 70ug
At least 10 and up to 33 participants will receive one (1) IBE-814. Route of administration: intravitreal injection.
IBE-814 140ug
Up to 27 participants will receive two (2) IBE-814. Route of administration: intravitreal injection.
Sydney Eye Hospital, Sydney
Sydney Retina Clinic, Sydney
Eye Doctors Mona Vale, Mona Vale
Strathfield Retina Clinic, Strathfield
Marsden Eye Specialist, Parramatta
Retina and Eye Consultants, Hurstville
Newcastle Eye Hospital, Waratah
Centre For Eye Research Australia, East Melbourne
Armadale Eye Clinic, Malvern
Eye Surgery Associates, Malvern
Queensland Eye Institute, South Brisbane
Princess Alexandra Hospital, Woolloongabba
Adelaide Eye and Retina Centre, Adelaide
Royal Adelaide Hospital, Adelaide
Lions Eye Institute, Nedlands
Southern Eye Specialists, Christchurch
Upton Eye Specialists, Brampton
Retina Centre Of Ottawa, Ottawa
Uptown Eye Specialists, Vaughan
Grantham Hospital, Aberdeen
Prince of Wales Hospital the Chinese University of Hong Kong, Hong Kong
Novotech (Australia) Pty Limited
INDUSTRY
Ripple Therapeutics Pty Ltd
INDUSTRY